TXN
33
-3
NSC
31
-2
KR
52
2
GD
52
-5
IR
66
-2
WEC
38
-7
CRM
59
7
AES
44
-3
BA
45
-2
C
46
2
SIG
8
-5
EIX
51
-2
FOXA
27
-3
THC
55
-4
BK
60
2
HBAN
45
-2
TJX
55
2
SHW
53
-5
CNX
46
-2
LRCX
42
-3
TXN
33
-3
NSC
31
-2
KR
52
2
GD
52
-5
IR
66
-2
WEC
38
-7
CRM
59
7
AES
44
-3
BA
45
-2
C
46
2
SIG
8
-5
EIX
51
-2
FOXA
27
-3
THC
55
-4
BK
60
2
HBAN
45
-2
TJX
55
2
SHW
53
-5
CNX
46
-2
LRCX
42
-3
Financhill
Back

Stoke Therapeutics Stock Predictions

Five Top Tech Stocks to Own Now

Click Here to Download the FREE Report
Sell
35

STOK
Stoke Therapeutics

Last Price:
11.75
Seasonality Move:
-0.04%

7 Day Trial

ALL ACCESS PASS

$ 7

The U.S. Government Just Invested $140 Million In WHAT?

And he shows you exactly how to take advantage right here, starting today.

Stoke Therapeutics Stock Forecast

  • Over the next 52 weeks, Stoke Therapeutics has on average historically fallen by 9% based on the past 3 years of stock performance.
  • Stoke Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Stoke Therapeutics Stock Undervalued?
    The current Stoke Therapeutics [STOK] share price is $11.76. The Score for STOK is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • STOK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Stoke Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Stoke Therapeutics has on average historically fallen by 9% based on the past 3 years of stock performance.

Stoke Therapeutics Stock Rating

Sell
35
Stoke Therapeutics (STOK) is a Sell

Is Stoke Therapeutics overpriced?

  • Stoke Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Stoke Therapeutics Stock Price History

Is STOK stock going to rise?

  • The current trend is moderately bullish and STOK is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
stoketherapeutics.com

52-Week Data

52-Week High:
22.87
52-Week Low:
6.88

Prediction Charts

Market Cap:
519.66M
Price in USD:
11.76
Volume:
149.91K
Beta:
0.40

Technical Analysis

SMA50:
10.16
SMA100:
9.58
SMA200:
10.55
52-Wk Change:
-7.84%

Stock Predictions

  • Is Stoke Therapeutics stock public?
    Yes, Stoke Therapeutics is a publicly traded company.
  • What is the Stoke Therapeutics stock quote today?
    The Stoke Therapeutics stock price is 11.76 USD today.
  • How to buy Stoke Therapeutics stock online?
    You can buy Stoke Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-22 11.23 11.30 11.65 11.23
May-23 11.63 11.90 12.64 11.53
May-24 11.79 11.03 11.93 10.95
May-25 10.95 10.61 10.95 10.40
May-26 10.62 10.92 11.09 10.62
May-30 10.92 10.85 11.28 10.46
May-31 10.89 11.20 11.29 10.54
Jun-1 11.20 11.29 11.34 10.69
Jun-2 11.41 12.17 12.20 11.36
Jun-5 12.14 12.50 12.87 12.11
Jun-6 12.34 13.20 13.49 12.30
Jun-7 13.15 13.08 13.40 12.86
Jun-8 13.07 12.69 13.20 12.69
Jun-9 12.71 11.76 12.71 11.68

Stoke Therapeutics Earnings

Stoke Therapeutics Earnings Report: Per Share Stoke Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Stoke Therapeutics Forecast Revenue Growth

Stoke Therapeutics Stock Analysis: Historical quarterly revenues per share for Stoke Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.00 per share, an increase next quarter of $0.11 per share, an increase this year of $0.10 per share, and a decrease next year of $0.34 per share.

* Stoke Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.